UltraPro Nasdaq Biotechnology - UBIO UltraPro Nasdaq Biotechnology

ProShares UltraPro Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index®.

This leveraged ProShares ETF seeks a return that is 3x the return of its underlying benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, ProShares' returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. Investors should monitor their holdings as frequently as daily. For more on risks, please read the prospectus.

  • Read more about ProShares UltraPro and UltraPro Short ETFs.
  • Learn more about considerations for geared investing.

Fund Snapshot

Ticker UBIO
Intraday Ticker UBIO.IV
CUSIP 74347B474
Inception Date 6/22/15
Expense Ratio * 0.95%
NAV Calculation Time 4:00 p.m. ET
Distributions Quarterly

* With Contractual Waiver ending 9/30/19.

Price Information as of 12/10/18

NAV $25.52
NAV Change $0.33
Market Price Closing $25.55
Market Price Closing Change $0.29
Daily Trading Volume 100,960

Performance

UBIO Performance Chart

Chart data from Thomson Reuters. Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded. Data is delayed at least 15 minutes.